SAT0271 Continued Improvement of Signs and Symptoms in Ustekinumab-Treated Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A674.2-A675
Keyword(s):
Phase 3
◽